منابع مشابه
New Drugs on the Horizon: Matrix Metalloproteinase Inhibitors.
Matrix metalloproteinases (MMPs) are a family of enzymes involved in a number of normal cellular processes, such as regulation of endometrial growth and menstruation, and abnormal processes, such as tumor growth, invasion, and metastasis. There are now 18 distinct enzymes that fall into three functional classifications based on their substrate target: collagenases which degrade fibrillar collag...
متن کاملTowards new tuberculosis drugs.
The need for better drugs to treat tuberculosis has never been greater. Despite insufficient funding for discovery research, intensive efforts have been made to find and develop new lead compounds capable of reducing the duration of the present treatment known as DOTS (directly observed therapy short course), from 6 to under 4 months. This minireview describes the progress achieved during the l...
متن کاملNew Drugs for Tuberculosis
There are good drugs to treat drug-sensitive tuberculosis in otherwise healthy, compliant patients, but everyone who treats tuberculosis knows that many of our patients fall outside of this group. Even in this " perfect setting " , therapy is too long and intolerance too frequent. After decades with few or no new medicines for tuberculosis, many drugs and drug-candidates are now being developed...
متن کاملNovel Antithrombotic Drugs on the Horizon
Diseases associated with arterial thrombosis or venous thrombosis are leading causes of mortality and morbidity globally. Since the 1930s, antithrombotic therapy has been the cornerstone of medical therapy for thrombotic diseases. However, the success of antithrombotic therapy has come at the cost of one of the most dreaded iatrogenic complications—bleeding. Recently, new evidence has emerged o...
متن کاملNew drugs for tuberculosis treatment.
Available data on anti-tuberculosis drug research reveal different properties of the agents and provoke speculation about future directions. Higher doses of the rifamycins are promising and are currently being evaluated in regimens of shorter duration that the isoniazid plus rifampin-based, six-to-nine month-course therapy. Moxifloxacin and gatifloxacin might shorten tuberculosis treatment as w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Opinion in Microbiology
سال: 2011
ISSN: 1369-5274
DOI: 10.1016/j.mib.2011.07.022